References
- Hasseltvedt V, Nilsen ø, Lystad A. HIV-situasjonen i Norge pr. 31. desember 1993. MSIS-rapport. Meldesystem for Infeksjons-sykdommer. Statens Institutt for Folkehelse, Norge 1993; 21: 3, [in Norwegian]
- Nilsen Ø, Lystad A, Hasseltvedt V. HIV-infeksjon – en vurdering av den epidemiologiske situasjonen i Norge. MSIS-rapport. Meldesystem for Infeksjons-sykdommer. Statens Institutt for Folkenhelse, Norge 1993; 21: 9, [in Norwegian]
- Lystad A. AIDS – Overvåking og kontroll. MSIS. Meldesystem for Infeksjons-sykdommer. Statens Institutt for Folkenhelse, Norge 1985; 24, [in Norwegian]
- Lystad A. AFIM. Kartlegging av HIV-infeksjon ved hjelp av melding om påvist HIV-antistoff. MSIS. Meldesystem for Infeksjons-sykdommer. Statens Institutt for Folkenhelse, Norge 1986; 38, [in Norwegian]
- Nilsen Ø, Lystad A, Hasseltvedt V. HIV/AIDS – en vurdering av den epidemiologiske situasjonen. MSIS-rapport. Meldesystem for Infeksjons-sykdommer. Statens Institutt for Folkehelse, Norge 1991; 19: 12, [in Norwegian]
- Cannon R O, Schmid G P, Moore P S, Pappaioanou M. Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985–1987. Sex Transm Dis 1989; 16: 184–189
- Siegel S. Non parametric Statistics for the Behavioral Sciences. McGraw-Hill, Tokyo 1959
- StatView TM. The graphic statistics utility for the MacintoshTM. Brainpower, Calabasas, CA 1985
- McCray E, Onorato I M. The Field Services Branch. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992; 19: 235–241
- Fennema J S, van Ameijden E J, Coutinho R A, van Doornum G J, Henquet C J, van den Hoek J A. HIV prevalence among clients attending a sexually transmitted disease clinic in Amsterdam: the potential risk for heterosexual transmission. Genitourin Med 1993; 69: 23–28
- The European Study Group. European Community Concerted Action on HIV seroprevalence among sexually transmitted disease patients in 18 European sentinel networks. AIDS 1993; 7: 393–400
- Quinn T C, Groseclose S L, Spence M, Provost V, Hook E W, 3d. Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience. J Infect Dis 1992; 165: 541–544
- Sherr L, Strong C. Safe sex and women. Genitourin Med 1992; 68: 32–35
- Moatti J-P, Le Gales C, Seror V, Papiernik E, Henrion R. Social acceptability of HIV screening among pregnant women. AIDS Care 1990; 2: 213–222
- Hull H F, Bettinger C J, Gallaher M M, Keller N M, Wilson J, Mertz G J. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA 1988; 260: 935–938
- Chiasson M A, Stoneburner R L, Lifson A R, Hildebrandt D S, Ewing W E, Schultz S, Jaffe H W. Risk factors for Human Immunodeficiency Virus type 1(HIV-1) infection in patients at a sexually transmitted disease clinic in New York City. Am J Epidemiol 1990; 131: 208–220
- Osborn J E. Sounding board – AIDS: politics and science. N Engl J Med 1988; 318: 444–447
- Fehrs L J, Foster L R, Fox V. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet 1988; 2: 379–381
- Dab W, Moatti J-P, Bastide S, Abenhaim L, Brunet J-B. Misconceptions about transmission of AIDS and attitudes toward prevention in the French general public. AIDS 1989; 3: 433–437